Executive Summary

Endocare/Aloka Ultrasound: Firms enter strategic alliance for the U.S. marketing of Endocare's Cryocare cryotherapy system for treating prostate cancer. Under the agreement, Aloka will help train users of the Cryocare system in the proper use of ultrasound with cryotherapy. In exchange, Aloka gains rights to sell its ultrasound systems to Endocare's customer base. "Having the strength of a premier ultrasound company like Aloka helping us market cryotherapy will result in a more complete presentation to our customers," Endocare says. The Cryocare system, which uses an argon gas-based cryogen, was cleared by FDA in mid-1995 and formally introduced by Endocare at the recent American Urological Association annual meeting in Orlando...